Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve 1. To Consider and Approve the unaudited standalone financial results for the quarter ended 31st December, 2025 along with Limited Review Report of the auditors;2. To Consider and approve the allotment of equity shares issued through preferential allotment basis.3. Any other matter with the permission of chair.
Novelix Pharmaceuticals Ltd Press Release Feb 09 2026
Filed with BSE · · 1 page · English
Release
Novelix Pharmaceuticals Ltd on 6ix
Earlier from Novelix Pharmaceuticals
- Novelix Pharmaceuticals Ltd Press Release Jan 11 2026
- Novelix Pharmaceuticals Ltd Press Release Jan 10 2026
- Novelix Pharmaceuticals Ltd Press Release Jan 09 2026
- Novelix Pharmaceuticals Ltd Press Release Dec 31 2025
- Novelix Pharmaceuticals Ltd Press Release Dec 26 2025
Later from Novelix Pharmaceuticals
- Novelix Pharmaceuticals Ltd Press Release Feb 12 2026
- Novelix Pharmaceuticals Ltd Press Release Feb 18 2026
- Novelix Pharmaceuticals Ltd Press Release Mar 30 2026
- Novelix Pharmaceuticals Ltd Press Release Apr 02 2026
- Novelix Pharmaceuticals Ltd Press Release Apr 09 2026
Follow Novelix Pharmaceuticals into a list and get an email when it puts out news.
Follow Novelix Pharmaceuticals